Health ❯Pharmaceuticals

Drug Development

Clinical Trials Cancer Drugs Weight Loss Drugs Alzheimer's Disease Innovative Therapies Oncology Biotechnology ALS Treatment Pain Management Therapeutics Alzheimer's Treatments Diabetes Drugs Targeted Therapy Molecular Therapy Targeted Therapies Antibiotic Discovery Biopharmaceuticals Eli Lilly Active Ingredients Moderna Regulatory Approval Regulatory Affairs Monoclonal Antibody Therapy Aging Interventions Antifungal Drugs AstraZeneca Clinical Development Life-Saving Drugs Protein Therapeutics Nanotechnology Drug Design Regulatory Issues Clinical Research GLP-1 Drugs Tirzepatide Vaccines Fluorinated Compounds Cancer Treatments Novel Therapies Addiction Treatment New Medications Stability Enhancement Cardiometabolic Diseases Market Potential Antidotes Clinical Use Vaccine Manufacturing First-in-Class Medications Stroke Prevention Market Competition Compounding Pharmacy New Treatments Telomerase Inhibitors Lifespan Extension Cancer Generic Drugs Antiviral Drugs Weight Loss Liver Condition Treatment Liver Disease Drugs Drug Formulation Revenue Targets Antibiotics Heart Failure Drug Epilepsy Treatment Therapies Weight-Loss Pill Modified Release Formulation Pricing Strategies Obesity Treatments Long-term Effects

Ebola Pill Shows Promise in Monkey Trials, Raising Hopes for Human Treatment

The antiviral drug obeldesivir demonstrated high survival rates in infected monkeys, offering potential for easier and broader outbreak management.

Stories older than 24h

Annual HIV Prevention Injection Shows Promise in Early Safety Trials

Novo Nordisk's CagriSema Falls Short in Latest Weight-Loss Trial for Diabetes Patients

Eli Lilly Targets Unapproved Weight-Loss Drugs with New Ad Campaign

Eli Lilly Expands Zepbound Access with New Doses and Lower Prices

FDA Approves Journavx, First Non-Opioid Painkiller in Over Two Decades

AstraZeneca Cancels £450m UK Vaccine Plant Expansion Over Funding Dispute

New Drug Regimens Revolutionize Treatment for Drug-Resistant Tuberculosis

Google DeepMind Spinoff Plans AI-Designed Drug Trials by Year-End

AI-Designed Proteins Show Promise in Neutralizing Snake Venom Toxins

Johnson & Johnson to Acquire Intra-Cellular Therapies in $14.6 Billion Deal

Galapagos Announces Plan to Split Into Two Public Companies by Mid-2025

Scientists Discover Faster mRNA Degradation Process Linked to Key Cellular Functions

Breakthrough Drug Delivery System Crosses Blood-Brain Barrier

Eli Lilly's Oral Drug Shows Promise in Lowering Genetic Cholesterol

DeepMind's AlphaFold 3 Goes Open Source, Boosting Drug Discovery

Caterpillar Fungus Compound Shows Promise in Slowing Cancer Cell Growth

Caterpillar Fungus Shows Promise in Cancer Treatment

EU Fines Teva $503 Million for Blocking MS Drug Competition

Eli Lilly Sues Vendors for Selling Unauthorized Tirzepatide Products

Xenon Pharmaceuticals to Showcase at BofA CNS Therapeutics Conference

Diabetes Drug Metformin Shows Promise in Slowing Brain Aging

Lenacapavir Injection Shows 96% Efficacy in Preventing HIV

Moderna's mRNA Vaccine Shows Superior Mpox Protection in Animal Studies

Sea Snail Venom Offers New Hope for Diabetes Treatment

Scientists Discover New Antibiotics in Human Gut Microbiome

Breakthrough in Understanding Protein Quality Control Mechanism

UCLA Researchers Develop Molecule That Restores Memory in Alzheimer's Model Mice

New HIV Drug Could Revolutionize Prevention at Just $40 Annually

Weight Loss Drug Adherence Drops, Companies Push for Oral Alternatives

Eli Lilly Acquires Morphic for $3.2 Billion

Alnylam's Heart Drug Shows Promising Phase-3 Results, Boosting Stock

Breakthrough in Male Birth Control: Reversible, Non-Hormonal Pill Shows Promise

Cytokinetics' $575M Royalty Deal Faces Investor Backlash

AstraZeneca Targets $80 Billion Revenue by 2030 with 20 New Medicines

Experts Warn of Superbugs Potentially Surpassing COVID-19 Impact

Varda Space Industries Secures $90 Million for Space-Based Drug Manufacturing Expansion

Viking Therapeutics' New Weight Loss Drug Shows Promising Trial Results

Vertex's Non-Opioid Painkiller Shows Promising Results in Mid-Stage Trial

Loyal's Life-Extending Drug for Large Dogs Receives Conditional FDA Approval